ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Detailed Segmentation:

• Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space (Revenue, USD Mn, 2021 - 2033)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Other

• Global Artificial Intelligence in Drug Discovery Market, By Application (Revenue, USD Mn, 2021 - 2033)

  • Drug Optimization & Repurposing
  • Preclinical Testing
  • Others

• Regional Insights (Revenue, USD Mn, 2021 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa

• Company Profiles:

  • IBM Corporation (Ibm Watson Health)
  • Exscientia
  • GNS Healthcare
  • Alphabet, Inc. (DEEPMIND)
  • Benevolent AI
  • Biosymetrics
  • Euretos
  • Berg LLC.
  • Atomwise, Inc.